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Abstract 
Background: In the setting of an acute myocardial infarction (AMI), although the most common etiology of a left 
ventricular (LV) mass identified on multimodality cardiovascular imaging is a thrombus, other possibilities including a 
vegetation or tumor should be entertained within the differential diagnosis.
Case presentation: We describe a case of a 43-year-old Caucasian female post AMI diagnosed with a mid-cavitary 
mass within the LV. Although echocardiography and cardiovascular MRI (CMR) suggested that the mass was a throm-
bus, given the context of the recent AMI, exploration and surgical excision was completed by the surgeon due to the 
potential for the mass to embolize.
Conclusion: The final diagnosis of a papillary fibroelastoma was unique due to its unusual location and large size 
within the LV cavity. This unique case demonstrates shortcomings of multimodality cardiac imaging in the diagnosis 
of an atypical mass and the importance of obtaining tissue when clinically safe and feasible.
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Background
Primary tumors of the heart are infrequent with an over-
all incidence of 0.02% based on autopsy series [1]. With 
the routine use of noninvasive imaging, cardiac tumors 
are often found incidentally. However, a left ventricular 
(LV) mid-cavitary mass is rarely seen and can challenge 
a clinicians’ diagnostic ability. The diagnosis relies on 
multimodality cardiovascular imaging, including echo-
cardiography, cardiac computed tomography (CCT), and 
cardiovascular magnetic resonance (CMR). The etiology 
of a LV mass can be determined by its location, attach-
ment, mobility, enhancement, and vascularity.
In the setting of an acute myocardial infarction (AMI), 
a LV mass is likely to represent a thrombus. Approxi-
mately 7% of patients with an anterior AMI develop a 
LV thrombus [2, 3], which is considerably more preva-
lent than primary cardiac tumors. Nonetheless, it is 
important to have a broad differential when approaching 
a LV cavitary mass, including thrombus, tumors, both 
benign and malignant, or rarely a vegetation.
We describe a case of a 43-year-old female post AMI 
diagnosed with a mid-cavitary mass within the LV. 
Despite the use of multimodality cardiovascular imaging, 
she required surgical excision for the rare diagnosis of a 
papillary fibroelastoma.
Case report
A 43-year-old Caucasian woman with type II diabetes, 
hypertension, dyslipidemia, and pre-existing ischemic 
heart disease (IHD), presented with a non ST-segment 
elevation myocardial infarction (NSTEMI). Coronary 
angiography demonstrated multi-vessel disease with 
severe in-stent restenosis of her proximal left anterior 
descending (LAD) and significant obstructive lesions in 
the proximal right coronary artery (RCA) and proximal 
obtuse marginal (OM) artery. Given the multi-vessel 
disease with two layers of stent and aggressive nature 
of her coronary artery disease, the patient was accepted 
for in-hospital coronary artery bypass grafting (CABG). 
A preoperative transthoracic echocardiogram (TTE) 
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confirmed a mass (23  ×  18  mm) within the LV cavity 
(Fig. 1a, b). Following the administration of Definity for 
LV opacification, the mass appeared avascular, mobile, 
with a broad based attachment to the mid anterior wall 
(Fig.  1c). Transesophageal echocardiogram confirmed 
the size and attachment of the LV mass to the ante-
rior wall (Fig.  1d). Cardiac magnetic resonance imag-
ing confirmed a LV mass measuring 1.3  cm adjacent 
to the akinetic mid-anterior wall (Fig. 1e, f ). Following 
the administration of gadolinium, delayed enhance-
ment imaging confirmed infarction of the mid to basal 
anterior wall without enhancement of the LV mass 
(Fig.  1g). As there was no evidence of late gadolinium 
enhancement of the LV mass on CMR, this would favor 
a presumed diagnosis of a LV thrombus. The patient 
underwent surgical resection of the mass via the aortic 
valve during a four vessel CABG procedure, including 
left internal mammary artery to LAD, left radial artery 
to posterior descending artery, saphenous venous graft 
to first obtuse marginal artery, and a second saphen-
ous venous graft to the second obtuse marginal artery. 
The gross specimen of the LV mass demonstrated a 
22  ×  16  ×  10  mm mass with a characteristic frond-
like appearance, suggestive of papillary fibroelastoma 
(Fig.  1h). Histopathological examination confirmed an 
avascular connective tissue core with adjacent fronds 
covered by endothelium consistent with a papillary 
fibroelastoma (Fig. 1i).
Discussion
Cardiac papillary fibroelastomas (PFE’s) are uncommon, 
benign, avascular cardiac tumors. With an estimated 
frequency as high as 0.33% on autopsy series, PFEs con-
stitute up to 7% of all primary cardiac tumors [4]. PFEs 
are typically found on the valvular surface of the heart, 
most commonly involving the aortic and mitral valves 
Fig. 1 a, b A parasternal long axis and short axis view on TTE demonstrating an echodense mass (23 × 18 mm) attached to the mid anteroseptal 
wall of the LV; c An apical 4 chamber view on TTE following the administration of Definity demonstrating the avascular nature of the mass within 
the LV cavity; d A midesophageal long axis view on TEE confirming the echodense mass attached to the mid anteroseptal wall; e, f A vertical long 
axis and short axis view on B-SSFP imaging using CMR demonstrating the location of the intracardiac mass within the LV cavity; g A short axis view 
on DE-CMR confirming infarction of the mid to basal anterior wall; h Gross specimen of the LV mass (22 × 16 × 10 mm); i Histopathological confir-
mation of an avascular connective tissue with fronds covered by endothelium consistent with a papillary fibroelastoma
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[5]. Non-valvular PFEs are exceedingly rare, with only 
55 patients identified in a systematic search of the lit-
erature using the MEDLINE database [6]. Although the 
pathophysiology of PFE is not entirely understood, there 
is a strong association with previous open-heart surger-
ies and thoracic radiation [7]. Damage to the endothe-
lium, trauma, and organizing emboli have been suggested 
mechanisms [8]. Although it is a benign tumor, PFE’s 
can present with ischemia or severe embolic sequelae, 
especially when the mass arises in the left side of the 
heart [9]. Surgical removal of PFE can reduce the risk of 
embolization.
Echocardiography is the most readily and cost effec-
tive imaging modality available to assess a LV mass. It 
provides basic information on mass morphology, mobil-
ity, position, and attachment. Contrast echocardiogra-
phy using Definity allows additional classification based 
on vascularity [7]. Despite its superior temporal resolu-
tion, ease of portability and real-time imaging, complete 
definition of cardiac masses may not be possible with 
echocardiography alone. Both CT and CMR allow high 
contrast resolution and evaluation of myocardial infiltra-
tion. CT has the benefit of delineating calcification of the 
mass, while CMR has the added benefits of the contrast 
agent gadolinium. Late gadolinium enhancement can be 
used to distinguish thrombi from tumor based on its lack 
of enhancement. It is also used to identify the presence, 
location and extent of an AMI [10]. Appropriate use of 
these various non-invasive cardiac imaging modalities 
often allows differentiation of the mass and a pre-opera-
tive diagnosis.
Our case presents a unique challenge to pre-operative 
diagnosis. Although echocardiography and CMR sug-
gested that the mass was a thrombus, given the context 
of the recent anterior MI, exploration and surgical exci-
sion was completed by the surgeon due to the potential 
for the mass to embolize. The final diagnosis of a PFE was 
unique due to its unusual location and large size within 
the LV cavity. This unique case demonstrates shortcom-
ings of multimodality cardiac imaging in the diagnosis of 
an atypical mass and the importance of obtaining tissue 
when clinically safe and feasible.
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